153 related articles for article (PubMed ID: 15889382)
21. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease.
Lepej SZ; Begovac J; Vince A
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807
[TBL] [Abstract][Full Text] [Related]
22. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
Peretz Y; Ndongala ML; Boulet S; Boulassel MR; Rouleau D; Côté P; Longpré D; Routy JP; Falutz J; Tremblay C; Tsoukas CM; Sékaly RP; Bernard NF
Clin Immunol; 2007 Jul; 124(1):57-68. PubMed ID: 17521962
[TBL] [Abstract][Full Text] [Related]
23. Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution.
Perrella A; Vitiello L; Atripaldi L; Conti P; Sbreglia C; Altamura S; Patarino T; Vela R; Morelli G; Bellopede P; Alone C; Racioppi L; Perrella O
Gut; 2006 Sep; 55(9):1370-1. PubMed ID: 16905711
[No Abstract] [Full Text] [Related]
24. Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function.
Lapinski TW; Parfieniuk A; Rogalska-Plonska M; Czajkowska J; Flisiak R
Liver Int; 2009 Sep; 29(8):1158-61. PubMed ID: 19602133
[TBL] [Abstract][Full Text] [Related]
25. CD38+CD8+ T-cells negatively correlate with CD4 central memory cells in virally suppressed HIV-1-infected individuals.
Kolber MA
AIDS; 2008 Oct; 22(15):1937-41. PubMed ID: 18784457
[TBL] [Abstract][Full Text] [Related]
26. Why should hepatitis C affect immune reconstitution in HIV-1-infected patients?
Graham CS; Koziel MJ
Lancet; 2000 Dec; 356(9245):1865-6. PubMed ID: 11130376
[No Abstract] [Full Text] [Related]
27. Correlation of T-lymphocyte subpopulations with immunological markers in HIV-1-infected Indian patients.
Kaushik S; Vajpayee M; Sreenivas V; Seth P
Clin Immunol; 2006 Jun; 119(3):330-8. PubMed ID: 16476571
[TBL] [Abstract][Full Text] [Related]
28. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
29. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
Grossman Z; Meier-Schellersheim M; Sousa AE; Victorino RM; Paul WE
Nat Med; 2002 Apr; 8(4):319-23. PubMed ID: 11927927
[No Abstract] [Full Text] [Related]
30. Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.
Stebbing J; Waters L; Mandalia S; Bower M; Nelson M; Gazzard B
Clin Infect Dis; 2005 Sep; 41(6):906-11. PubMed ID: 16107994
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
32. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
[TBL] [Abstract][Full Text] [Related]
33. Do Vgamma2Vdelta2 T cells influence HIV disease progression?
Nunnari G
Clin Infect Dis; 2008 May; 46(9):1473-5. PubMed ID: 18419458
[No Abstract] [Full Text] [Related]
34. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
[TBL] [Abstract][Full Text] [Related]
35. Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV-positive, HCV-negative patients.
Kosmas N; Kontos A; Panayiotakopoulos G; Dimitrakopoulos A; Kordossis T
J Med Virol; 2006 Oct; 78(10):1257-61. PubMed ID: 16927287
[TBL] [Abstract][Full Text] [Related]
36. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
37. Effect of hepatitis C virus genotype on CD4+ T cell count in a cohort of antiretroviral-naive HIV-1-infected individuals.
Antonucci G; Cozzi-Lepri A; Girardi E; Capobianchi MR; De Luca A; d'Arminio Monforte A;
J Infect Dis; 2005 Aug; 192(4):703-4; author reply 704-5. PubMed ID: 16028141
[No Abstract] [Full Text] [Related]
38. Infection fighters. Large study finds hepatitis C virus infection linked to reduced benefit from anti-HIV drugs.
TreatmentUpdate; 2001; 12(8):3-4. PubMed ID: 12132438
[No Abstract] [Full Text] [Related]
39. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
[TBL] [Abstract][Full Text] [Related]
40. Cellular immune responses against hepatitis C virus.
Koziel MJ
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S25-31. PubMed ID: 16265610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
